Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mark A, Evashenk"'
Autor:
Bruce Ben-David, Mark A. Evashenk, Harold S. Minkowitz, David W. Griffin, Maurice Jove, Pamela Pierce Palmer
Publikováno v:
Anesthesiology. 123:434-443
Background: Complications with IV patient-controlled analgesia include programming errors, invasive access, and impairment of mobility. This study evaluated an investigational sufentanil sublingual tablet system (SSTS) for the management of pain afte
Publikováno v:
Journal of Trauma and Acute Care Surgery. 77:S198-S203
BACKGROUND: Sufentanil sublingual microtablets (SSMs) at a dose of 15 Hg per tablet have been studied for postoperative patient-controlled analgesia with a 20-minute lockout via a bedside handheld system over 2 days to 3 days of use. For more short-t
Autor:
Maurice, Jove, David W, Griffin, Harold S, Minkowitz, Bruce, Ben-David, Mark A, Evashenk, Pamela P, Palmer
Publikováno v:
Anesthesiology. 123(2)
Complications with IV patient-controlled analgesia include programming errors, invasive access, and impairment of mobility. This study evaluated an investigational sufentanil sublingual tablet system (SSTS) for the management of pain after knee or hi
Autor:
Pamela P. Palmer, Forrest G. Ringold, Tong J. Gan, Keith A. Aqua, Yu-Kun Chiang, Harold S. Minkowitz, Mark A. Evashenk
Publikováno v:
Regional Anesthesia and Pain Medicine
Background and Objectives This study evaluates the efficacy and safety of a sufentanil sublingual tablet system (SSTS) for the management of postoperative pain following open abdominal surgery. Methods At 13 hospital sites in the United States, patie
Autor:
Pamela P. Palmer, Sandra K. Willsie, Stephen S. Hwang, Mark A. Evashenk, Lawrence Hamel, Yu-Kun Chiang
Publikováno v:
Clinical therapeutics. 37(1)
Purpose Sufentanil is a μ-opioid agonist with a high therapeutic index in preclinical studies and no active metabolites, and it is highly lipophilic, thereby enabling a transmucosal route of administration. Rapid distribution from the plasma after I
Autor:
Timothy I. Melson, Alparslan Turan, Mark A. Evashenk, Harold S. Minkowitz, David L Boyer, Yu-Kun Chiang, Pamela P. Palmer
Publikováno v:
Pain Practice
Background Problems with intravenous patient-controlled analgesia (IV PCA) are well known, including invasive route of delivery and pump programming errors. The primary objective of this study was to evaluate patient satisfaction with a novel subling
Autor:
Mark A. Evashenk, Pamela Pierce Palmer, Harold S. Minkowitz, Maurice Jove, Bruce Ben-David, David W. Griffin
Publikováno v:
Survey of Anesthesiology. 60:38
Background:Complications with IV patient-controlled analgesia include programming errors, invasive access, and impairment of mobility. This study evaluated an investigational sufentanil sublingual tablet system (SSTS) for the management of pain after
Autor:
Neil Singla, Pamela P. Palmer, Stephen S. Hwang, Yu-Kun Chiang, Mark A. Evashenk, Lawrence Hamel, Harold S. Minkowitz
Publikováno v:
Regional anesthesia and pain medicine. 38(2)
A sublingual sufentanil tablet is being developed as a potential alternative to intravenous (IV) opioids for the management of postoperative pain. The objective of these studies was to evaluate the pharmacokinetics, efficacy, and safety of sublingual
Autor:
Sandra K. Willsie1, Mark A. Evashenk2, Lawrence G. Hamel2, Stephen S. Hwang, Yu-Kun Chiang3, Pamela P. Palmer2 ppalmer@acelrx.com
Publikováno v:
Clinical Therapeutics. Jan2015, Vol. 37 Issue 1, p145-155. 11p.